Open- | Close- |
Vol / Avg.0 / 1.117M | Mkt Cap669.736M |
Day Range- - - | 52 Wk Range4.430 - 19.340 |
Cabaletta Bio Stock (NASDAQ: CABA) stock price, news, charts, stock research, profile.
Open- | Close- |
Vol / Avg.0 / 1.117M | Mkt Cap669.736M |
Day Range- - - | 52 Wk Range4.430 - 19.340 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.400 | -0.370 | 0.0300 | ||||
REV | 0 |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.440 | -0.370 | 0.0700 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-11-29 | Morgan Stanley | Michael Ulz | Maintains | OverweightOverweight | Lowers | 28.00 | 25.00 |
2023-11-29 | HC Wainwright & Co. | Douglas Tsao | Reiterates | BuyBuy | Maintains | - | 25.00 |
2023-11-15 | Cantor Fitzgerald | Joshua Schimmer | Maintains | OverweightOverweight | Raises | 40.00 | 50.00 |
2023-11-10 | HC Wainwright & Co. | Douglas Tsao | Maintains | BuyBuy | Raises | 17.00 | 25.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
CABA | Cabaletta Bio | 0% | 669.7M |
ETNB | 89bio | 0.4% | 756.4M |
RNA | Avidity Biosciences | 0.65% | 615.2M |
FDMT | 4D Molecular Therapeutics | 0% | 580.2M |
AMAM | Ambrx Biopharma | 0% | 764.1M |
You can purchase shares of Cabaletta Bio (NASDAQ: CABA) through any online brokerage.
Other companies in Cabaletta Bio’s space includes: 89bio (NASDAQ:ETNB), Avidity Biosciences (NASDAQ:RNA), 4D Molecular Therapeutics (NASDAQ:FDMT), Ambrx Biopharma (NASDAQ:AMAM) and Cogent Biosciences (NASDAQ:COGT).
The latest price target for Cabaletta Bio (NASDAQ: CABA) was reported by Morgan Stanley on Wednesday, November 29, 2023. The analyst firm set a price target for 25.00 expecting CABA to rise to within 12 months (a possible 59.95% upside). 24 analyst firms have reported ratings in the last year.
The stock price for Cabaletta Bio (NASDAQ: CABA) is $15.63 last updated December 5, 2023 at 9:00 PM UTC.
There is no dividend information for Cabaletta Bio.
Cabaletta Bio’s Q3 earnings are confirmed for Thursday, November 9, 2023.
There is no upcoming split for Cabaletta Bio.
Cabaletta Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.